Birtamimab

Birtamimab (NEOD001) is an investigational monoclonal antibody that specifically and selectively target and clear the amyloid. Birtamimab can be used for the research of light chain amyloidosis[1].

Product Specifications

CAS Number

[1608108-91-3]

Product Name Alternative

NEOD001

UNSPSC

12352203

Target

Amyloid-β

Type

Inhibitory Antibodies

Related Pathways

Neuronal Signaling

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/birtamimab.html

Purity

99.93

Solubility

H2O

Smiles

[Birtamimab]

Molecular Weight

(146.44 kDa)

References & Citations

[1]AGertz M, et, al. Birtamimab in Patients with Mayo Stage IV AL Amyloidosis: Rationale for Confirmatory Affirm-AL Phase 3 Study Design. Journal home page for Blood. Volume 138, Supplement 1, 23 November 2021, Page 2754.